Evidence map›Paper›PMID 42112291›Full record

ArticleIranian journal of microbiology2026

Drug susceptibility of

Zahra Mirhosseini, Jamshid Razmyar, Alireza Khosravi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zahra MirhosseiniDepartment of Avian Diseases, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Jamshid RazmyarDepartment of Avian Diseases, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Alireza KhosraviDepartment of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: The prevalence of Materials and Methods: Totally 126 samples were analyzed, from which 116 distinct colonies were cultured. Of these, 26 were identified as Results: According to the CLSI M44 recommended method, by the disk diffusion method, itraconazole (100%) and amphotericin B (86.46%) showed the best susceptibility pattern, compared to caspofungin (0%). Conclusion: Given that the isolates showed the highest in vitro susceptibility to itraconazole and amphotericin B and the lowest to caspofungin, these findings suggest that itraconazole and amphotericin B could be considered potential first-line agents for treating avian candidiasis.

Indexed as

Antifungal agentsAntimicrobial susceptibility testsBirdsCandida albicansDrug resistanceFungal

Identifiers

PMID42112291
PMCPMC13156831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.